Quantum biopharma announces private placement

Toronto, june 27, 2025 (globe newswire) -- quantum biopharma ltd. (nasdaq: qntm) (cse: qntm) (fra: 0k91) ("quantum biopharma" or the "company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class a multiple voting shares (“mvs”) at a price of $50 per mvs, for aggregate gross proceeds of up to $600 (the “offering”). the company expects that the entirety of the offering will be subscribed for by the existing holders of mvs.
QMCO Ratings Summary
QMCO Quant Ranking